|
|
 |
 |
 |
CALIFORNIA Stanford
Stanford University Scleroderma Center
Stanford University Medical Center
450 Broadway St.
Department of Dermatology
Pavilion B, 4th floor
Redwood City, CA 94063
Clinic information: Adult patients seen with systemic sclerosis, localized scleroderma, and other related connective tissue diseases
Hours: Monday-Friday, 8am-5pm dependent on individual doctor's office hours. Multi-disciplinary Rheumatologic Dermatology Clinic Monday afternoons.
Appointments:
Abigail Agustin--650-721-7119 (phone); 650-721-3476 (fax); aagustin@stanfordmed.org
Physician Inquiries: Contact Lorinda Chung at 650-493-5000 ext. 62042 or shauwei@stanford.edu
Research Coordinators:
Amanda Foster--650-721-7147 (phone); 650-618-1681 (fax); amfoster@stanford.edu
Val Scott and Susan Jacobs—650-725-8082 (phone); valval@stanford.edu and ssjpulm@stanford.edu
| Studies |
Status |
PHAROS: Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma |
Active recruiting |
| MEDI-551: A Phase 1, Randomized, Double-blind, Placebo-controlled Study of the Safety and Tolerability of MEDI-551 in Scleroderma |
Active recruiting |
| Rituximab in SSc-APAH: A Randomized, Double-blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) in the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension |
Active recruiting |
| An Open-Label Clinical Trial of Ambrisentan and Tadalafil Combination Therapy in Pulmonary Arterial Hypertension Associated with the Scleroderma Spectrum of Disease |
Active recruiting |
| Revision of SSc Classification Criteria |
Active recruiting |
| Outcomes and Clinical Biomarkers for Scleroderma |
Active recruiting |
| Proteomics of Inflammation, Immunity and Pulmonary Arterial Hypertension |
Active recruiting |
Physicians affiliated with this center:
Rheumatology:
Dermatology:
- David Fiorentino, MD, PhD
- Howard Chang, MD, PhD
Pulmonary:
- Mark Nicolls, MD
- Glenn Rosen, MD
- Roham Zamanian, MD
Gastroenterology:
Hand/Vascular:
Cardiology:
|
CALIFORNIA San Francisco 
University of California San Francisco
Scleroderma Program
UCSF Arthritis Center
400 Parnassus Avenue Plaza Level
San Francisco, CA 94143-0326
Clinic Information:
Adult patients with systemic and localized scleroderma
Hours: Mon-Fri 8:30 am – 5 pm, dependent on individual doctor’s hours. Interdisciplinary clinic Friday AM
Appointments:
Phone: (415) 353-2497
Fax: (415) 353-2530
Online appointment requests: https://www.ucsfhealth.org/appointments/rheumatology/index.html
Contact: tamiko.katsumoto@ucsfmedctr.org
Research Coordinators: Archer Eller & Darren Leong (415) 353-2060, fax (415) 353-2674, email: archer.eller@ucsf.edu
UCSF Websites:
Scleroderma Clinic: http://www.ucsfhealth.org/clinics/scleroderma/
Interstitial Lung Disease Clinic: www.ucsfhealth.org/ild
Pulmonary Hypertension Clinic: http://www.ucsfhealth.org/clinics/pulmonary_hypertension_clinic/
Physicians affiliated with this center:
Rheumatologists:
- Tamiko Katsumoto, M.D.
- Andrew Gross, M.D.
Dermatologist:
Pulmonologists:
- Jeffrey Golden, M.D.
- Paul Wolters, M.D.
- Hubert Chen, M.D.
Cardiologists:
- Teresa DeMarco, M.D.
- Dana McGlothlin, M.D.
|
 CALIFORNIA
Los
Angeles
University of California
Division of Rheumatology
1000 Veteran Avenue
Rehab Center Room 32-59
Box 951670
Los Angeles, CA 90095-1670
Telephone: 310-825-8414 and 310-825-4744
Fax:310-206-8606
Contacts:
Sarah Delgado at sedelgado@mednet.ucla.edu
| Studies |
Status |
Scleroderma Lung Study 2
http://sls.med.ucla.edu/nav6.html |
Open |
| Ambrisentan in Patients with Scleroderma |
Open |
CRISS: Provisional Combined Response Index For Patients With Diffuse Systemic Sclerosis |
Open |
DETECT: A Study to Determine The Best Methods to Determine if Patients Have Pulmonary Arterial Hypertension in Patients With Scleroderma |
Open |
DISTOL: a study using Treprostinil Diethanolamine (UT-15C) or Placebo Subjects With Scleroderma |
Open |
Imatinib (Gleevac) in Subjects with Systemic Sclerosis |
Closed |
Quality of Life |
Open |
SCOT study (Scleroderma Cyclophosphamide
Or Transplantation)
www.clinicaltrials.gov/ct/gui/show/NCT00114530 |
Open |
The Natural History and Outcome of Patients with Scleroderma at High Risk for or with Early Pulmonary Hypertension (PHAROS) |
Open |
|
Trials that will be opening soon at UCLA are:
- Dasatinib for Subjects With Scleroderma
- MEDI-546 in Subjects With Scleroderma
|
Physician Affiliated with this Center:
Philip Clements, M.D., M.P.H.
Daniel Furst, M.D. |
|
